Search
lersivirine
Indications:
- treatment of HIV1
Dosage:
- 500 or 750 mg PO QD
Notes:
- in clinical trials
Interactions
drug adverse effects of antiretroviral agents
General
non-nucleoside reverse transcriptase inhibitor (NNRTI)
Database Correlations
PUBCHEM cid=16739244
References
- Vernazza P et al.
Efficacy and safety of lersivirine (UK-453,061) versus
efavirenz in antiretroviral treatment - naive HIV-1 - patients:
Week 48 primary analysis results from an ongoing, multicenter,
randomized, double-blind, phase IIb trial.
J Acquir Immune Defic Syndr 2013 Feb 1; 62:171.
PMID: 23328090